|
RAD50 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30970000000475E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.7845999999957E-05 |
| Normal-vs-Stage2 |
8.180100E-02 |
| Normal-vs-Stage3 |
1.77427999999979E-05 |
| Normal-vs-Stage4 |
4.233500E-04 |
| Stage1-vs-Stage2 |
2.734800E-01 |
| Stage1-vs-Stage3 |
2.971600E-01 |
| Stage1-vs-Stage4 |
7.269400E-01 |
| Stage2-vs-Stage3 |
1.065560E-01 |
| Stage2-vs-Stage4 |
2.350000E-01 |
| Stage3-vs-Stage4 |
6.775000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44179999999705E-05 |
| Normal-vs-AfricanAmerican |
1.483620E-02 |
| Normal-vs-Asian |
4.391500E-04 |
| Caucasian-vs-AfricanAmerican |
7.695800E-01 |
| Caucasian-vs-Asian |
8.118200E-01 |
| AfricanAmerican-vs-Asian |
6.715000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62954999999299E-05 |
| Normal-vs-Female |
2.021500E-04 |
| Male-vs-Female |
1.754640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.799200E-04 |
| Normal-vs-Age(41-60Yrs) |
5.66810000000029E-05 |
| Normal-vs-Age(61-80Yrs) |
6.191000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.541830E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.657800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.789600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.036800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.372800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.624600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.386200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.133800E-01 |
| Classical-VS-Follicular |
8.892200E-02 |
| Classical-VS-Other |
1.365810E-01 |
| Classical-VS-Normal |
7.767000E-04 |
| Tall-VS-Follicular |
9.300800E-01 |
| Tall-VS-Other |
3.828600E-01 |
| Tall-VS-Normal |
5.849000E-04 |
| Follicular-VS-Other |
4.342400E-01 |
| Follicular-VS-Normal |
1.802850E-04 |
| Other-VS-Normal |
4.701200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.97479999999906E-05 |
| Normal-vs-N1 |
3.90150000000311E-05 |
| N0-vs-N1 |
2.989600E-01 |
|
|
